Research Topics
Species | Alastair ForbesSummaryAffiliation: Imperial College Country: UK Publications
| Collaborators
|
Detail Information
Publications
Differential immunohistochemical expression of syndecan-1 and tumor necrosis factor alpha in colonic mucosa of patients with Crohn's diseaseMariabeatrice Principi
Gastroenterology Unit, Ospedali Riuniti, Foggia, Italy
Immunopharmacol Immunotoxicol 28:185-95. 2006..However, the expression of the two molecules is inversely related when a single field is considered, these data supporting the possibility of a downregulation exerted by TNFalpha...
Acupuncture for irritable bowel syndrome: a blinded placebo-controlled trialAlastair Forbes
St Mark s Hospital, Watford Road, Harrow HA1 3UJ, United Kingdom
World J Gastroenterol 11:4040-4. 2005..Irritable bowel syndrome (IBS) is a common disorder and many patients fail to find adequate relief from conventional therapies for their symptoms. This study tests the claim that acupuncture is effective for a majority of these patients...
Investigation of diarrhoea in adultsAlastair Forbes
St Mark's Hospital and Academic Institute, Imperial College of Science, Technology and Medicine, Harrow, Middlesex
Clin Med 2:410-4. 2002
Crohn's disease: the cold chain hypothesisAlastair Forbes
St Mark s Hospital and Academic Institute, Watford Road, Harrow, HA1 3UJ, UK
Int J Colorectal Dis 21:399-401. 2006..3, 10.9 and 15.0 years for Crohn's disease, UC and controls, respectively). This support for the hypothesis reached statistical significance for those with Crohn's disease compared to the controls (p=0.045)...
Achieving and maintaining venous access for home parenteral nutritionAlastair Forbes
St Mark s Hospital and Academic Institute, Harrow, UK
Curr Opin Clin Nutr Metab Care 8:285-9. 2005..Means to preserve venous access are therefore crucial...
Parenteral nutritionAlastair Forbes
St Mark s Hospital, Harrow, UK
Curr Opin Gastroenterol 21:192-6. 2005....
Regulation of epithelial syndecan-1 expression by inflammatory cytokinesRichard M Day
IBD Research Group, St Mark s Hospital, Watford Road, Harrow, Middlesex HA1 3UJ, UK
Cytokine 21:224-33. 2003..TNF-alpha and IL-1beta are capable of down-regulating syndecan-1 expression and may account in part for the reduced expression of syndecan-1 seen in IBD...
Alternative immunomodulatorsAlastair Forbes
St Mark s Hospital and Academic Institute, Harrow, UK
Eur J Gastroenterol Hepatol 15:245-8. 2003..The biological agents, however, bring a more novel and potentially powerful approach. Natalizumab, and targeted mucosal delivery of interleukin-10 already show considerable promise...
Microscopic colitis: the tip of the iceberg?Paul A Kitchen
Northwick Park and St Mark s Hospitals, Harrow, UK
Eur J Gastroenterol Hepatol 14:1199-204. 2002..The aims were to determine whether a wide variation exists between hospitals in the diagnosis of microscopic colitis and to assimilate clinical data...
Safe and efficacious prolonged use of an olive oil-based lipid emulsion (ClinOleic) in chronic intestinal failureSiwan Thomas-Gibson
St. Mark's Hospital, Watford Road, Harrow HA1 3UJ, UK
Clin Nutr 23:697-703. 2004..4%, 1.5%, and 2.6% of feeding days, respectively. One patient died (pneumonia). One new case of cholecystolithiasis appeared. CONCLUSION: ClinOleic may be used as a safe alternative to standard soybean-oil-based lipid emulsions...
Muramyl dipeptide and toll-like receptor sensitivity in NOD2-associated Crohn's diseaseDavid A van Heel
Intestinal Inflammation and Repair Group, Department of Gastroenterology, Imperial College London, UK
Lancet 365:1794-6. 2005....
Association of DLG5 R30Q variant with inflammatory bowel diseaseMark J Daly
The Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA, USA
Eur J Hum Genet 13:835-9. 2005..This study provides support for the hypothesis that DLG5 constitutes a true IBD risk factor of modest effect...
Parenteral nutritionAlastair Forbes
Department of Gastroenterology and Clinical Nutrition, University College Hospital, London, UK
Curr Opin Gastroenterol 23:183-6. 2007..The past 12 months have seen advances in the safe use of intravenous nutrition and its place in the therapeutic armamentarium...
IL23R variation determines susceptibility but not disease phenotype in inflammatory bowel diseaseMark Tremelling
IBD Research Group, Addenbrooke s Hospital, University of Cambridge, Cambridge, England, UK
Gastroenterology 132:1657-64. 2007..We tested for association between IL23R and IBD in a large independent UK panel to determine the size of the effect and explore subphenotype correlation and interaction with CARD15...
Detection of muramyl dipeptide-sensing pathway defects in patients with Crohn's diseaseDavid A van Heel
Institute of Cell and Molecular Science, Barts and The London, Queen Mary s School of Medicine and Dentistry, London, UK
Inflamm Bowel Dis 12:598-605. 2006..Rare NOD2 variants occur, but it is difficult to both identify them and assess their functional effect. We assessed the true frequency of defective muramyl dipeptide sensing in Crohn's disease and developed a rapid diagnostic assay...
Investigation of association of the DLG5 gene with phenotypes of inflammatory bowel disease in the British populationAlexandra V Pearce
Department of Medical and Molecular Genetics, King s College London School of Medicine, 8th Floor Guy s Tower, Guy s Hospital, London SE1 9RT, UK
Int J Colorectal Dis 22:419-24. 2007....
Genetic variation in myosin IXB is associated with ulcerative colitisAdriaan A van Bodegraven
Department of Gastroenterology, VU University Medical Centre, Amsterdam, The Netherlands
Gastroenterology 131:1768-74. 2006..These findings suggested the current study investigating a possible further role for MYO9B variation in inflammatory bowel disease...
Plasma citrulline concentration: a reliable marker of small bowel absorptive capacity independent of intestinal inflammationCinzia Papadia
Department of Gastroenterology, University College Hospital, London, United Kingdom
Am J Gastroenterol 102:1474-82. 2007..The aim of this study was to address the potentially confounding impact of intestinal inflammation...
Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetesEleftheria Zeggini
Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Churchill Hospital, Oxford, OX3 7LJ, UK
Science 316:1336-41. 2007..The regions identified underscore the importance of pathways influencing pancreatic beta cell development and function in the etiology of type 2 diabetes...
Diverse effects of the CARD15 and IBD5 loci on clinical phenotype in 630 patients with Crohn's diseaseClive M Onnie
Division of Genetics and Molecular Medicine, King s College London School of Medicine, Guy s Hospital, London, UK
Eur J Gastroenterol Hepatol 20:37-45. 2008..We studied 630 well-characterized patients to clarify the genotype/phenotype relationship in CD...
Survival of patients identified as candidates for intestinal transplantation: a 3-year prospective follow-upLoris Pironi
Department of Clinical Medicine, University of Bologna, Italy
Gastroenterology 135:61-71. 2008..The American Society of Transplantation also includes patients at high risk of death from their primary disease or with high morbidity intestinal failure. A 3-year prospective study evaluated the appropriateness of these indications...
Common variants near MC4R are associated with fat mass, weight and risk of obesityRuth J F Loos
MRC Epidemiology Unit, Addenbrooke s Hospital, Cambridge CB2 0QQ, UK
Nat Genet 40:768-75. 2008....
A nonsynonymous SNP in ATG16L1 predisposes to ileal Crohn's disease and is independent of CARD15 and IBD5Natalie J Prescott
Department of Medical and Molecular Genetics, King s College London School of Medicine, Guy s Hospital, London, UK
Gastroenterology 132:1665-71. 2007..We investigated this association in independent U.K. cohorts of Crohn's disease and ulcerative colitis...
Genetic determinants of ulcerative colitis include the ECM1 locus and five loci implicated in Crohn's diseaseSheila A Fisher
Department of Medical and Molecular Genetics, King s College London School of Medicine, 8th Floor Guy s Tower, Guy s Hospital, London SE1 9RT, UK
Nat Genet 40:710-2. 2008..These data provide the first detailed illustration of the genetic relationship between these common inflammatory bowel diseases...
Combined evidence from three large British Association studies rejects TUCAN/CARD8 as an IBD susceptibility geneSheila A Fisher
Gastroenterology 132:2078-80. 2007
Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibilityMiles Parkes
Inflammatory Bowel Disease Research Group, Addenbrooke s Hospital, University of Cambridge, Cambridge CB2 2QQ, UK
Nat Genet 39:830-2. 2007..We obtained replication for the autophagy-inducing IRGM gene on chromosome 5q33.1 (replication P = 6.6 x 10(-4), combined P = 2.1 x 10(-10)) and for nine other loci, including NKX2-3, PTPN2 and gene deserts on chromosomes 1q and 5p13...
Idiopathic sclerosing peritonitisYashwant Koak
Department of General Surgery, Basildon Hospital, Nethermayes, Basildon, London, UK
Eur J Gastroenterol Hepatol 20:148-50. 2008..The patient continues to have chronic intestinal failure, managed conservatively by long-term parenteral nutrition and steroids for more than 12 years...
Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variantsPaul R Burton
Genetic Epidemiology Group, Department of Health Sciences, University of Leicester, Adrian Building, University Road, Leicester LE1 7RH, UK
Nat Genet 39:1329-37. 2007....
Recruiting first-degree relatives for prevention research: a comparison of clinician and proband-led methods of contact in Crohn's diseaseErin P Reid
Department of Psychology, Health Psychology Section, Institute of Psychiatry, King's College London, London, UK
Eur J Hum Genet 14:1263-8. 2006..High levels of interest in research across the two recruitment methods suggest that although proband-led methods may maximise privacy, they may deny relatives the opportunity to take part in research that would be of interest...
Candidates for intestinal transplantation: a multicenter survey in EuropeLoris Pironi
Department of Internal Medicine and Gastroenterology, University of Bologna, Bologna, Italy
Am J Gastroenterol 101:1633-43; quiz 1679. 2006..CONCLUSIONS: The rate of candidacy and the indications for ITx candidacy differed greatly among age groups and HPN centers; within countries candidacy was more homogeneous; physicians had a generally reserved attitude toward ITx...
Sex stratification of an inflammatory bowel disease genome search shows male-specific linkage to the HLA region of chromosome 6Sheila A Fisher
Division of Medical and Molecular Genetics, Guy s, King s and St Thomas School of Medicine, King s College London, UK
Eur J Hum Genet 10:259-65. 2002..The existence of sex-specific linkage is further evidence of the complex mechanisms involved in IBD and will facilitate future studies to identify susceptibility genes...
Pharmacogenomics of response to anti-tumor necrosis factor therapy in patients with Crohn's diseaseAjeya Shetty
St Mark's Hospital and Academic Institute, Harrow, England
Am J Pharmacogenomics 2:215-21. 2002..This is a rapidly changing field, and more information of greater direct clinical benefit can be expected soon...
Review article: Immunosuppressants in distal ulcerative colitisG Falasco
Department of Gastroenterology, St Mark's Hospital, Watford Road, Harrow, HA1 3UJ, UK
Aliment Pharmacol Ther 16:181-7. 2002..CONCLUSIONS: Immunosuppression appears to be of lower efficacy and higher toxicity in resistant distal colitis than when used in more extensive colitis...
Potential therapeutic role for cytokine or adhesion molecule manipulation in Crohn's disease: in the shadow of infliximab?Alan Shand
St Mark s Hospital, Watford Road, Harrow, HA1 3UJ, UK
Int J Colorectal Dis 18:1-11. 2003..These agents have considerable potential which, in combination with new delivery systems (perhaps taking into account some form of genetic engineering), hold great promise...
Genetic evidence for interaction of the 5q31 cytokine locus and the CARD15 gene in Crohn diseaseMuddassar M Mirza
Division of Medical and Molecular Genetics, Guy s, King s, and Thomas s School of Medicine, King s College London, Guy s Hospital, London, United Kingdom
Am J Hum Genet 72:1018-22. 2003..0019). These findings suggest that genetic variants at the 5q31 (IBD5) locus may hasten the onset of Crohn disease and cooperate with CARD15 in disease causation...
Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitisMatthew Rutter
Department of Gastroenterology, University Hospital of North Tees, Stockton on Tees, Teesside, England
Gastroenterology 126:451-9. 2004..Patients with ulcerative colitis are at increased risk of colorectal cancer. It is widely believed that this is secondary to colonic inflammation. However, the severity of colonic inflammation has never been shown to be a risk factor...
Use of fecal lactoferrin to diagnose irritable pouch syndrome: a word of cautionMatthew Warren Johnson
Gastroenterology 127:1647-8; author reply 1648. 2004
Intestinal growth in parenterally-fed rats induced by the combined effects of glucagon-like peptide 2 and epidermal growth factorPaul A Kitchen
St Mark's Hospital, Imperial College London, Harrow, United Kingdom
JPEN J Parenter Enteral Nutr 29:248-54. 2005..CONCLUSIONS: Both GLP-2 and EGF upregulate growth of the small intestine, and this is augmented when GLP-2 and EGF are combined. These findings may lead to improved treatment of patients receiving PN...
Infliximab use in Crohn's disease: impact on health care resources in the UKDerek P Jewell
Gastroenterology Unit, University of Oxford, Sheffield, UK
Eur J Gastroenterol Hepatol 17:1047-52. 2005..To quantify the impact of infliximab therapy on health care resource utilization in the UK...
Mutation, selection, and evolution of the Crohn disease susceptibility gene CARD15Kathy King
Department of Medical and Molecular Genetics, Guy s, King s and St Thomas School of Medicine, King s College London, London, United Kingdom
Hum Mutat 27:44-54. 2006..The strategy developed here may have general application to the assessment of mutation pathogenicity and genetic models in other complex disorders...
Parenteral nutritionAlastair Forbes
Department of Gastroenterology and Clinical Nutrition, University College Hospital, London, UK
Curr Opin Gastroenterol 22:160-4. 2006..During the past 12 months there have been clinically important advances in intravenous nutrition and adjunctive therapies...
Associations of allelic variants of the multidrug resistance gene (ABCB1 or MDR1) and inflammatory bowel disease and their effects on disease behavior: a case-control and meta-analysis studyClive M Onnie
Department of Medical and Molecular Genetics, King s College London School of Medicine, Guy s Hospital, UK
Inflamm Bowel Dis 12:263-71. 2006....
Intangible costs and benefits of ulcerative colitis surveillance: a patient surveyMatthew D Rutter
University Hospital of North Tees, Stockton on Tees, Cleveland, United Kingdom
Dis Colon Rectum 49:1177-83. 2006..Colonoscopic surveillance in ulcerative colitis has costs and benefits beyond cancer prevention, which might influence program efficacy. This study assesses the more intangible aspects of surveillance...
Does cross-reactivity between mycobacterium avium paratuberculosis and human intestinal antigens characterize Crohn's disease?Dimitrios Polymeros
University College London, London, United Kindgom
Gastroenterology 131:85-96. 2006..Our aim was to seek amino acid similarities between MAP and intestinal proteins that, through molecular mimicry, could serve as targets for cross-reactive immunity in CD...
Direct or indirect association in a complex disease: the role of SLC22A4 and SLC22A5 functional variants in Crohn diseaseSheila A Fisher
Department of Medical and Molecular Genetics, King s College London School of Medicine, Guy s Hospital, London, United Kingdom
Hum Mutat 27:778-85. 2006....
The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel diseaseAndrew P Cuthbert
Division of Medical and Molecular Genetics, Guy s, King s, and St Thomas School of Medicine, London, England, United Kingdom
Gastroenterology 122:867-74. 2002....
